SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has rallied to a fresh 52-week high as traders position ahead of the Q3 report, focusing on BRIUMVIs sales growth and possible guidance changes. The move has also fueled unconfirmed Sanofi buyout and short-squeeze speculation, while some traders caution that the rally may have priced in strong results.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Berkshires disclosed accumulation of a large Lennar stake has fueled bargain-buying interest, but traders are debating it against Hunterbrooks short-report allegations about Lennars transactions with spinoff Millrose. The dispute adds to concerns over weak results and outlook, pressured affordability, and elevated mortgage rates.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

A Northland upgrade citing C3 Code as a potential growth driver for agentic AI has renewed interest in C3.ai, alongside unusual call-option activity and short-squeeze speculation. Traders are divided between optimism about the product and enterprise AI demand, and concern over declining revenue and continued losses.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave shares are drawing attention amid a steep selloff across quantum-computing stocks, with traders questioning whether high valuations, limited near-term commercialization and competition from classical AI can support the sector ahead of Q3 results. Some see the pullback as a buying opportunity, while others expect more downside.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in London, Canada.

Aduro Clean Technologies Inc

Aduros reported pilot results showing high condensable-hydrocarbon yields across polypropylene and mixed polyolefin feeds are driving discussion, alongside progress toward its planned first-of-a-kind facility. Bulls see the results and engineering work as validation of its plastics-recycling technology, while skeptics argue that yields do not establish commercial economics or scalability.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

Discussion centers on REalloys potential role in a North American rare-earth and magnet supply chain, with traders pointing to U.S. defense sourcing restrictions taking effect in 2027 and the companys Army-linked Tooele project and Tanbreez offtake as longer-term catalysts. Bulls see strategic demand upside, while bears focus on the lack of recent operational updates, execution and dilution risks, and sharp volatility.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

BLZE is under pressure after a steep pullback, with traders pointing to broader tech weakness and CoreWeaves decline while positioning around the upcoming earnings report. The community is split between dip-buyers betting on strong results or new contracts and cautious traders concerned that earnings could bring further losses.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is falling amid a broad semiconductor selloff that traders attribute largely to Intels weak forward guidance, with some also pointing to bearish put-option activity. The community is split between buying the pullback and expecting further downside, while noting the drop appears tied more to sector pressure than a clear Qualcomm-specific catalyst.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

MAGS is drawing attention amid a pullback and debate over whether mega-cap tech can justify its heavy AI spending, with traders citing cash-flow pressure and bubble risk. Others view the weakness as a buying opportunity and expect money to rotate back from semiconductors into the Magnificent Seven.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

Ionis and AstraZenecas Wainua Phase 3 ATTR-CM trial missed its primary endpoint, drawing attention to potential competitive read-through for Alnylams TTR franchise and upcoming cardiomyopathy pipeline. Traders are divided: some view the failure as removing a rival and strengthening Amvuttras position, while others see it as raising broader questions about TTR silencers and increasing risk around Alnylams development plans.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Verisk Analytics (VRSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Verisk (VRSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thomson Reuters' AI Push Gains Steam: Is TRI Poised for Growth?

TRI is advancing AI products, raising its 2026 growth outlook and selling a majority stake in Global Print to sharpen its strategic focus.

Here's Why You Should Hold VRSK Stock in Your Portfolio Now

Verisk's recurring subscription revenues, AI-driven innovations and insurance analytics growth support its prospects despite rising costs and market headwinds.

Why Verisk Analytics (VRSK) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

All You Need to Know About Verisk (VRSK) Rating Upgrade to Buy

Verisk (VRSK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AI-Led Growth & Strong Cash Generation Support VRSK Amid High Debt

Verisk is expanding AI, cloud and catastrophe analytics as strong cash flow supports growth, but higher debt and rising costs could pressure margins.

Verisk Analytics Q2 2026 Earnings Call Transcript

Verisk Analytics (NASDAQ:VRSK) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call.
This transcript is brought to you by Benzinga APIs. For real-time access toread more...

Zacks Industry Outlook Highlights FactSet, Verisk and TransUnion

FactSet, Verisk and TransUnion are leveraging AI, proprietary data and subscription platforms as information services evolve.

3 Stocks to Consider From the Booming Business Information Industry

AI, proprietary data and cloud platforms are reshaping business information services. FDS, VRSK and TRU are positioned to benefit.

Here's Why You Should Retain Verisk Stock in Your Portfolio Now

VRSK's subscription-led growth, AI upgrades and acquisitions bolster insurance capabilities, while rising debt and staffing costs pose risks.

Verisk Analytics, Inc. engages in the provision of data, analytics, and technology services. The firm also offers predictive analytics and decision support solutions to clients in rating, underwriting, claims, catastrophe, and weather risk fields. It operates through the Insurance segment. The Insurance segment offers fraud-detection solutions including review of data on claim histories, analysis of claims to find emerging patterns of fraud, and identification of suspicious claims in the insurance sector and offers solutions and services primarily through annual subscriptions or long-term agreements. The company was founded in 1971 and is headquartered in Jersey City, NJ.

Verisk Analytics Inc

Verisk Terminates $2.35 Billion AccuLynx Acquisition Amid FTC Deadline Delay

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>AccuLynx has notified Verisk that it believes the termination of the merger is invalid.&nbsp;</li><li>Verisk also announced the redemption of $1.5 billion of senior notes issued in relation to the acquisition at 101% of principal plus accrued and unpaid interest.</li><li>Verisk had announced plans to acquire AccuLynx for $2.35 billion in July 2025.</li></ul>Verisk Analytics Inc. (VRSK) announced on Monday that it has cancelled its acquisition of AccuLynx after the Federal Trade Commission (FTC) failed to complete the transaction’s review by the specified deadline date of Dec. 26, 2025.The global insurance data analytics company had agreed to purchase AccuLynx, a SaaS platform, for $2.35 billion in July 2025. The deal was expected to be completed by the third quarter of 2025.Meanwhile, AccuLynx has notified Verisk that it believes the termination of the merger is invalid. Verisk said that it strongly disagrees with the assertion and will defend its stance.Shares of VRSK were up 0.5% at the time of writing.<h2 class="st-heading-2">Debt Redemption</h2>Verisk also said it will redeem $1.5 billion of senior notes issued in relation to the acquisition. The redemption will be at 101% of the principal amount plus accrued and unpaid interest as of the redemption date.After the debt redemption, Verisk’s leverage would have been 1.9x trailing twelve-month adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) as of Sept. 30, 2025. The company had $1.2 billion capacity left over under its share repurchase authorization.“Verisk remains committed to our capital allocation discipline – balancing organic investment in our highest return on capital opportunities while returning capital to shareholders through dividend and repurchases. We continue to have confidence in our ability to deliver results in line with our long-term growth targets for this year, for 2026 and beyond,” said Lee Shavel, president and CEO of Verisk.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/VRSK">VRSK shares</a> jumped to ‘bullish’ from ‘neutral’ territory over the past day, while message levels remained at ‘low’ levels at the time of writing.<figure class="image"><img style="aspect-ratio:1292/155;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_29_at_7_57_53_PM_png_33cfd2efd7.webp" alt="On Stocktwits, retail sentiment around VRSK shares jumped to ‘bullish’ from ‘neutral’ territory over the past day, while message levels remained at ‘low’ levels at the time of writing." width="1292" height="155"></figure>Shares of VRSK have lost over 20% of their value in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

The Verisk Analytics, Inc. logo appears on a smartphone screen in this illustration photo in Reno, United States, on December 31, 2024. (Photo Illustration by Jaque Silva/NurPhoto via Getty Images)

Verisk Analytics said it has cancelled the AccuLynx acquisition after the Federal Trade Commission failed to complete its review by the Dec. 26, 2025, deadline. 

Dimensional ETF Trust - Dimensional US High Profitability ETF

ProShares S&P 500 Ex-Health Care ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$196.30
Prev Close	$190.71
Open	$196.37
Dividend Yield	0.80%
50-Day Moving Average	$181.56
Beta	0.15
Avg. Volume	1.27M
PE Ratio	30.16

52-Week High	$227.16
52-Week Low	$155.94
Market Capitalization	$25.55B
EPS (Annual)	$6.48
Price to Book	-21.49
Revenue Per Employee	$384,087.50

Feed

News

Sentiment

Earnings

Fundamentals

Info

VRSK Fundamentals